Anti‐tumor activity of tumor necrosis factor in combination with interferon‐γ is not affected by prior tolerization

International Journal of Cancer

Volumn 63, Issue 6, 1995, Pages 846-854

  Takahashi, Nozomi ^a   Fiers, Walter ^a   Brouckaert, Peter ^a  

^a DEPARTMENT OF PLANT SYSTEMS BIOLOGY   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; GAMMA INTERFERON; RECOMBINANT PROTEIN; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL; ARTICLE; C57BL MOUSE; DOSE RESPONSE; DRUG TOLERANCE; FEMALE; LEWIS CARCINOMA; LYMPHOMA; MELANOMA; MOUSE;

ANIMALS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, LEWIS LUNG; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG TOLERANCE; FEMALE; INTERFERON TYPE II; LYMPHOMA; MELANOMA; MICE; MICE, INBRED C57BL; RECOMBINANT PROTEINS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0029642299     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.2910630616     Document Type: Article

References (23)

1. Human tumor xenografts treated with recombinant human tumor necrosis factor alone or in combination with interferons
2. Dissociation of TNF‐a cytotoxic and proinflammatory activities by p55 receptor‐ and p75 receptor‐selective TNF‐a mutants
3. In vivo anti‐tumour activity of recombinant human and murine TNF, alone and in combination with murine IFN‐gamma, on a syngeneic murine melanoma
4. Selective species specificity of tumor necrosis factor for toxicity in the mouse
5. Biologic therapy with TNF: preclinical studies
6. Impact of tolerance on antitumor efficacy of tumor necrosis factor in mice
7. Molecular cloning of mouse tumour necrosis factor cDNA and its eukaryotic expression
8. Recombinant tumor necrosis factor: its effect and its synergism with interferon‐7 on a variety of normal and transformed human cell lines
9. Specific suppression elicited by EL4 lymphoma cells in syngeneic mice. Specificity includes self‐antigens on EL4
10. Persistence of the hypertriglyceridemic effect of tumor necrosis factor despite development of tachyphylaxis to its anorectic/cachectic effects in rats
11. The selection and characterization of an invasive variant of the B16 melanoma
12. The antitumor function of tumor necrosis factor (TNF). 1. Therapeutic action of TNF against an established murine sarcoma is indirect, immunologically dependent and limited by severe toxicity
13. Clinical experience with high‐dose tumor necrosis factor alpha in regional therapy of advanced melanoma
14. Cloning and expression of cDNAs for two distinct murine tumor necrosis factor receptors demonstrate one receptor is species specific
15. High‐dose recombinant tumor necrosis factor alpha in combination with interferon gamma and melphalan in isolation perfusion of the limbs for melanoma and sarcoma
16. Molecular cloning and expression of human tumor necrosis factor and comparison with mouse tumor necrosis factor
17. Stimulation of RNA synthesis in L‐929 cells by rabbit tumor necrosis factor
18. Development of partial tolerance to the gastrointestinal effects of high doses of recombinant tumor necrosis factor‐a in rodents
19. Induction of tolerance allows separation of lethal and antitumor activities of tumor necrosis factor in mice
20. Mechanism of tolerance to tumor necrosis factor: receptor‐specific pathway and selectivity
21. The two different receptors for tumor necrosis factor mediate distinct cellular responses
22. Functional characterization of the human tumor necrosis factor receptor p75 in a transfected rat/mouse T cell hybridoma
23. Metastatic heterogeneity of cells from Lewis lung carcinoma